GENENTA SCIENCE SPA - ADR (GNTA) Stock Price, Forecast & Analysis
NASDAQ:GNTA • US36870W1009
GNTA Key Statistics, Chart & Performance
The current stock price of GNTA is 0.9996 USD. In the past month the price decreased by -25.4%. In the past year, price decreased by -74.76%.
GNTA Technical Analysis
GNTA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to GNTA. While GNTA seems to be doing ok healthwise, there are quite some concerns on its profitability.
GNTA Financial Highlights
Over the last trailing twelve months GNTA reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS increased by 3.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -40.37% | ||
| ROE | -71.82% | ||
| Debt/Equity | 0.62 |
GNTA Forecast & Estimates
7 analysts have analysed GNTA and the average price target is 7.14 USD. This implies a price increase of 614.29% is expected in the next year compared to the current price of 0.9996.
GNTA Ownership
GNTA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.48 | 397.325B | ||
| AMGN | AMGEN INC | 16.63 | 201.795B | ||
| GILD | GILEAD SCIENCES INC | 16.97 | 187.839B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.39 | 120.999B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.78 | 82.427B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 50.19 | 44.414B | ||
| INSM | INSMED INC | N/A | 35.17B | ||
| NTRA | NATERA INC | N/A | 29.514B | ||
| BIIB | BIOGEN INC | 12.62 | 28.182B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.06 | 20.385B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About GNTA
Company Profile
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. The company is headquartered in Milan, Milano and currently employs 13 full-time employees. The company went IPO on 2021-12-15. The firm focuses on the development of lentivirus-based gene and cell therapies in cancer. The company uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The firm not only operates locally but also is present in global markets, including the United States.
Company Info
GENENTA SCIENCE SPA - ADR
Via dell’Annunciata 31
Milan MILANO IT
Employees: 13
GENENTA SCIENCE SPA - ADR / GNTA FAQ
Can you describe the business of GENENTA SCIENCE SPA - ADR?
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. The company is headquartered in Milan, Milano and currently employs 13 full-time employees. The company went IPO on 2021-12-15. The firm focuses on the development of lentivirus-based gene and cell therapies in cancer. The company uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The firm not only operates locally but also is present in global markets, including the United States.
Can you provide the latest stock price for GENENTA SCIENCE SPA - ADR?
The current stock price of GNTA is 0.9996 USD. The price increased by 9.03% in the last trading session.
What is the dividend status of GENENTA SCIENCE SPA - ADR?
GNTA does not pay a dividend.
What is the ChartMill rating of GENENTA SCIENCE SPA - ADR stock?
GNTA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What sector and industry does GENENTA SCIENCE SPA - ADR belong to?
GENENTA SCIENCE SPA - ADR (GNTA) operates in the Health Care sector and the Biotechnology industry.
What is the ownership structure of GENENTA SCIENCE SPA - ADR (GNTA)?
You can find the ownership structure of GENENTA SCIENCE SPA - ADR (GNTA) on the Ownership tab.
What is the outstanding short interest for GENENTA SCIENCE SPA - ADR?
The outstanding short interest for GENENTA SCIENCE SPA - ADR (GNTA) is 1.54% of its float.